| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Talen Energy Corp | 10%+ Owner | Common Stock | 4,453,131 | $1,074,139,728 | $241.21 | 27 Jun 2025 | Indirect |
| COLLEGIUM PHARMACEUTICAL, INC | 10%+ Owner | Common Stock, par value $0.001 per share | 3,132,743 | $118,574,322 | $37.85 | 13 Aug 2025 | Indirect |
| Radius Health, Inc. | 10%+ Owner | Common Stock, par value $0.0001 per share ("Common Stock") | 8,642,271 | $87,027,669 | $10.07 | 11 Aug 2022 | Indirect |
| Mereo BioPharma Group plc | 10%+ Owner | American Depositary Shares ("ADSs") | 15,307,347 | $61,076,315 | $3.99 | 17 Jun 2024 | Indirect |
| HERON THERAPEUTICS, INC. /DE/ | 10%+ Owner | Common Stock, par value $0.01 per share ("Common Stock") | 30,046,828 | $37,859,003 | $1.26 | 15 Oct 2025 | Indirect |
| Talen Energy Corp | 10%+ Owner | Common Stock | 52,171 | $12,584,166 | $241.21 | 25 Jun 2025 | Direct |
| TherapeuticsMD, Inc. | Director, Other*, 10%+ Owner | Common Stock, par value $0.001 per share ("Common Stock") | 2,946,908 | $6,718,950 | $2.28 | 15 Nov 2023 | Indirect |
| Mereo Biopharma Group plc | 10%+ Owner | Ordinary Shares, GBP 0.003 par value per share | 31,950,000 | 01 Jan 2024 | Indirect | ||
| Vincerx Pharma, Inc. | 10%+ Owner | Common stock, par value $0.0001 per share | 2,107,000 | 20 Jan 2022 | Indirect | ||
| HERON THERAPEUTICS, INC. /DE/ | 10%+ Owner | Series A Convertible Preferred Stock ("Preferred Shares") | 0 | 15 Oct 2025 | Indirect | ||
| HERON THERAPEUTICS, INC. /DE/ | 10%+ Owner | Convertible Senior Unsecured Promissory Notes ("Notes") | $35,000,000 | 15 Oct 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 15 Oct 2025 | 2 | $0 | 4 | 10%+ Owner | 17 Oct 2025, 18:00 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 13 Aug 2025 | 1 | -$946,250 | 4 | 10%+ Owner | 15 Aug 2025, 16:12 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 08 Aug 2025 | 3 | +$39,999,988 | 4 | 10%+ Owner | 12 Aug 2025, 18:00 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 07 Aug 2025 | 0 | $0 | 3 | 10%+ Owner | 15 Aug 2025, 16:10 |
| TLN | Talen Energy Corp | 25 Jun 2025 | 22 | -$114,091,990 | 4 | 10%+ Owner | 27 Jun 2025, 18:45 |
| TLN | Talen Energy Corp | 13 Dec 2024 | 2 | -$999,999,900 | 4 | 10%+ Owner | 16 Dec 2024, 16:00 |
| TLN | Talen Energy Corp | 09 Jul 2024 | 0 | $0 | 3 | 10%+ Owner | 09 Jul 2024, 16:30 |
| MREO | Mereo BioPharma Group plc | 17 Jun 2024 | 1 | +$6,999,856 | 4 | 10%+ Owner | 17 Jun 2024, 17:16 |
| MREO | Mereo Biopharma Group plc | 01 Jan 2024 | 0 | $0 | 3 | 10%+ Owner | 02 Jan 2024, 16:00 |
| TXMD | TherapeuticsMD, Inc. | 15 Nov 2023 | 1 | +$1,999,998 | 4 | Director, Other*, 10%+ Owner | 17 Nov 2023, 09:27 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 21 Jul 2023 | 0 | $0 | 3 | 10%+ Owner | 25 Jul 2023, 16:15 |
| TXMD | TherapeuticsMD, Inc. | 28 Jun 2023 | 1 | +$1,149,998 | 4 | Director, Other*, 10%+ Owner | 29 Jun 2023, 17:21 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 30 Jan 2023 | 0 | $0 | 3 | Other* | 08 Feb 2023, 17:23 |
| TXMD | TherapeuticsMD, Inc. | 30 Dec 2022 | 1 | -$38,657,000 | 4/A | Director, Other*, 10%+ Owner | 22 Feb 2023, 15:32 |
| TXMD | TherapeuticsMD, Inc. | 09 Dec 2022 | 1 | +$90,284 | 4 | 10%+ Owner | 12 Dec 2022, 10:14 |
| TXMD | TherapeuticsMD, Inc. | 07 Dec 2022 | 2 | +$115,639 | 4 | 10%+ Owner | 09 Dec 2022, 09:58 |
| TXMD | TherapeuticsMD, Inc. | 28 Oct 2022 | 1 | +$7,000,000 | 4 | 10%+ Owner | 31 Oct 2022, 12:12 |
| TXMD | TherapeuticsMD, Inc. | 30 Sep 2022 | 1 | +$7,000,000 | 4 | 10%+ Owner | 03 Oct 2022, 17:40 |
| /report/000110465922089894-rubric-capital-management-lp-2022-08-10 | Radius Health, Inc. | 10 Aug 2022 | 1 | +$16,907,067 | 4 | 10%+ Owner | 12 Aug 2022, 12:06 |
| /report/000110465922089124-rubric-capital-management-lp-2022-08-10 | Radius Health, Inc. | 10 Aug 2022 | 1 | +$40,401 | 4 | 10%+ Owner | 11 Aug 2022, 10:43 |
| TXMD | TherapeuticsMD, Inc. | 29 Jul 2022 | 2 | +$14,999,950 | 4 | 10%+ Owner | 01 Aug 2022, 18:11 |
| TXMD | TherapeuticsMD, Inc. | 15 Jul 2022 | 2 | +$467,458 | 4 | 10%+ Owner | 19 Jul 2022, 11:28 |
| TXMD | TherapeuticsMD, Inc. | 14 Jul 2022 | 0 | $0 | 3 | 10%+ Owner | 19 Jul 2022, 11:14 |
| VINC | Vincerx Pharma, Inc. | 20 Jan 2022 | 0 | $0 | 3 | 10%+ Owner | 31 Jan 2022, 09:55 |
| /report/000110465921150598-rubric-capital-management-lp-2021-12-16 | Radius Health, Inc. | 16 Dec 2021 | 1 | +$1,037,752 | 4 | 10%+ Owner | 16 Dec 2021, 16:32 |
| /report/000110465921150068-rubric-capital-management-lp-2021-12-13 | Radius Health, Inc. | 13 Dec 2021 | 3 | +$3,191,376 | 4 | 10%+ Owner | 15 Dec 2021, 16:22 |
| /report/000110465921148720-rubric-capital-management-lp-2021-12-08 | Radius Health, Inc. | 08 Dec 2021 | 3 | +$12,015,792 | 4 | 10%+ Owner | 10 Dec 2021, 17:01 |
| /report/000110465921148583-rubric-capital-management-lp-2021-12-08 | Radius Health, Inc. | 08 Dec 2021 | 0 | $0 | 3 | 10%+ Owner | 10 Dec 2021, 15:15 |